These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 12427889)

  • 1. Megalencephaly in NF1: predominantly white matter contribution and mitigation by ADHD.
    Cutting LE; Cooper KL; Koth CW; Mostofsky SH; Kates WR; Denckla MB; Kaufmann WE
    Neurology; 2002 Nov; 59(9):1388-94. PubMed ID: 12427889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using a semi-automated approach to quantify Unidentified Bright Objects in Neurofibromatosis type 1 and linkages to cognitive and academic outcomes.
    Harriott EM; Nguyen TQ; Landman BA; Barquero LA; Cutting LE
    Magn Reson Imaging; 2023 May; 98():17-25. PubMed ID: 36608909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling neuronal and metabolic alterations in neurofibromatosis type 1.
    Botero V; Tomchik SM
    J Neurodev Disord; 2024 Aug; 16(1):49. PubMed ID: 39217323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation.
    Hernandez DP; Cruz DM; Martinez CS; Garcia LM; Figueroa A; Villarreal M; Manoj LM; Lopez S; López-Lorenzo KD; López-Juárez A
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new era for myelin research in Neurofibromatosis type 1.
    de Blank P; Nishiyama A; López-Juárez A
    Glia; 2023 Dec; 71(12):2701-2719. PubMed ID: 37382486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter is increased in the brains of adults with neurofibromatosis 1.
    Wang S; Friedman JM; Suppa P; Buchert R; Mautner VF
    Orphanet J Rare Dis; 2022 Mar; 17(1):115. PubMed ID: 35248131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in brain morphology by MRI in adults with neurofibromatosis 1.
    Wang S; Mautner VF; Buchert R; Flibotte S; Suppa P; Friedman JM; Heran MKS
    Orphanet J Rare Dis; 2021 Nov; 16(1):462. PubMed ID: 34727946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Oncological Neuroradiological Manifestations in NF1 and Their Clinical Implications.
    Russo C; Russo C; Cascone D; Mazio F; Santoro C; Covelli EM; Cinalli G
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-wide structural and functional disruption in mice with oligodendrocyte-specific
    Asleh J; Shofty B; Cohen N; Kavushansky A; López-Juárez A; Constantini S; Ratner N; Kahn I
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22506-22513. PubMed ID: 32839340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating indicators of CNS disorders in a swine model of neurological disease.
    Swier VJ; White KA; Meyerholz DK; Chefdeville A; Khanna R; Sieren JC; Quelle DE; Weimer JM
    PLoS One; 2020; 15(2):e0228222. PubMed ID: 32074109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.
    Kaczorowski JA; Smith TF; Shrewsbury AM; Thomas LR; Knopik VS; Acosta MT
    Behav Genet; 2020 Jul; 50(4):191-202. PubMed ID: 32026187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental Aspects of RASopathies.
    Kim YE; Baek ST
    Mol Cells; 2019 Jun; 42(6):441-447. PubMed ID: 31250618
    [No Abstract]   [Full Text] [Related]  

  • 13. Discriminating between neurofibromatosis-1 and typically developing children by means of multimodal MRI and multivariate analyses.
    Nemmi F; Cignetti F; Assaiante C; Maziero S; Audic F; Péran P; Chaix Y
    Hum Brain Mapp; 2019 Aug; 40(12):3508-3521. PubMed ID: 31077476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Morphology of Select Cortical and Subcortical Regions in Neurofibromatosis Type 1.
    Barkovich MJ; Tan CH; Nillo RM; Li Y; Xu D; Glastonbury CM; Glenn OA; Dillon WP; Hess CP; Mueller S; Kline C; Dale AM; Jernigan TL; Sugrue LP; Barkovich AJ; Desikan RS
    Radiology; 2018 Nov; 289(2):499-508. PubMed ID: 30179114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy Mechanisms in Neurocutaneous Disorders: Tuberous Sclerosis Complex, Neurofibromatosis Type 1, and Sturge-Weber Syndrome.
    Stafstrom CE; Staedtke V; Comi AM
    Front Neurol; 2017; 8():87. PubMed ID: 28367137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study.
    Violante IR; Patricio M; Bernardino I; Rebola J; Abrunhosa AJ; Ferreira N; Castelo-Branco M
    Neurology; 2016 Aug; 87(9):897-904. PubMed ID: 27473134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.
    Petrella LI; Cai Y; Sereno JV; Gonçalves SI; Silva AJ; Castelo-Branco M
    Genes Brain Behav; 2016 Sep; 15(7):637-46. PubMed ID: 27283753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms.
    Huijbregts SC; Loitfelder M; Rombouts SA; Swaab H; Verbist BM; Arkink EB; Van Buchem MA; Veer IM
    J Neurodev Disord; 2015; 7():32. PubMed ID: 26473019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1.
    Tomson SN; Schreiner MJ; Narayan M; Rosser T; Enrique N; Silva AJ; Allen GI; Bookheimer SY; Bearden CE
    Hum Brain Mapp; 2015 Nov; 36(11):4566-81. PubMed ID: 26304096
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.